In the News

Nathan Smith, senior vice president of products at Appriss Retail, will be joined by Christopher McGourty of NAORCA to discuss how AI can be used to identify fraud and reduce organized retail crime at the Florida Crime & Intelligence Analysts…

Opioid prescription intelligence software that is designed to integrate data from prescription drug monitoring programs into EHR systems is helping healthcare providers identify opioid-use disorder and improve prescribing practices, according to a…

The Georgia Department of Public Health is teaming up with Appriss Health to integrate the state’s prescription drug monitoring program into EHR systems across Georgia.

The opioid epidemic is a growing and complex problem. In fact, the Centers for Disease Control (CDC) estimates that more than 71,000 people in the U.S. died from drug overdose deaths in 2017.

This week, Appriss Health has launched ApprissID, a patient record-matching solution based on machine learning and consolidation algorithms within PMP AWARxE, Appriss Health’s prescription drug monitoring program (PDMP) solution that serves 44…

This session on May 7th at the RILA Asset Protect conference will include Chris Hoffman, Appriss Retail’s senior program manager, as well as two speakers from PetSmart.

Employee theft and fraud are costly problems for the retail industry, and the best techniques for reducing it are continuing to evolve. On this recorded webinar, two of the biggest names in retail risk management—First Advantage and Appriss…

Round table discussion led by Ken George, EMEA Business Development Manager, at Retail Risk London on 11 April 2019.

A private-equity firm will make a significant investment in Appriss Holdings Inc. and will become an equal partner in the company with Appriss management and another investor.

…

Partners HealthCare is the first health system to fully integrate the Massachusetts opioid monitoring tool directly into its EHR.